SARS-CoV-2 research and testing
The ongoing global challenges posed by emerging infectious diseases, such as COVID-19, underscore the growing need for advanced point-of-care diagnostics. Swift and decentralized testing for pathogen presence or antibodies against SARS-CoV-2, combined with a widespread vaccination effort, is imperative for effective disease control and addressing public health concerns worldwide.
Manufacturing of diagnostic chips
BioFluidix dispensing solutions streamline your processing tasks for diagnostic chip layouts, accommodating nanoliter or microliter volumes in both R&D and production.
Efficiently dispense ultra-low volumes of reagents and polymers into the cavities of your diagnostic chip, whether it features a circular or rectangular layout with one or multiple cavities. With our technology, you can precisely deposit your desired droplet volume in any pattern on any layout of your point-of-care test device, offering unparalleled flexibility for your applications.
Lateral flow testing
Development or manufacturing of test strips for the detection of antibodies against SARS-CoV-2
- non-contact processing of membranes or other substrates
- Print lines or any other droplet patterns
- Dynamic droplet volume range to adjust line width or spot size